Scientists test if common heart pill does its job
NCT ID NCT07281014
Summary
This study aims to understand if a standard low dose of a common heart failure drug (spironolactone) fully blocks the effects of a harmful hormone called aldosterone. Researchers will give 20 stable heart failure patients infusions of this hormone and the drug in different combinations to measure its effects on the body's salt and water balance. The goal is to gather biological information to see if current treatment doses are optimal.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yale University
RECRUITINGNew Haven, Connecticut, 06510, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.